Risks for HAEMONETICS CORP (HAE)
Here are some interesting risks from the recent filings of HAEMONETICS CORP. Our algorithms work hard to highlight risks unique to this company.
If our business strategy does not yield the expected results or we fail to implement the necessary changes to our operations, we could see material adverse effects on our business, financial condition or results of operations.
If we are unable to successfully launch our NexSys PCS plasmapheresis system, our business may be materially and adversely affected.
We may not realize the benefits we expect from our Complexity Reduction Initiative.
We outsource certain aspects of our business to a single third-party vendor that subjects us to risks, including disruptions in business and increased costs.
A significant portion of our revenue derives from the sale of blood collection supplies. Declines in the number of blood collection procedures have adversely impacted our business and future declines may have an adverse effect on our business, financial condition and results of operations.